Protagonist Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Protagonist Therapeutics using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-07 | $-0.54 | $-0.63 | 14.3 % |
Jun 2024 | 2024-08-06 | $-0.50 | $-0.60 | 16.7 % |
Mar 2024 | 2024-05-07 | $3.26 | $2.51 | 29.9 % |
Dec 2023 | 2024-02-27 | $0.44 | $-0.03 | 1566.7 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Sep 2024 | 2024-11-07 | $4.68M | $2.07M | 125.7 % |
Jun 2024 | 2024-08-06 | $4.17M | $8.00M | -47.9 % |
Mar 2024 | 2024-05-07 | $254.95M | $120.00M | 112.5 % |
Dec 2023 | 2024-02-27 | $60.00M | $40.00M | 50.0 % |
Protagonist Therapeutics ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 7, 2024 for Q3.
Protagonist Therapeutics ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 7, 2024 for Q3 and the Actual EPS was $-0.54, which beat the estimate of $-0.63.
Protagonist Therapeutics ({quoteSymbol}) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 7, 2024 for Q3 and the Actual EPS was {{actualEPS}}, which beat the estimate of {{estEPS}}.
Browse earnings estimates, EPS, and revenue on all stocks.